Table 17a. Persons living with a diagnosis of HIV infection, by race/ethnicity and selected characteristics, year-end 2007—37 states with confidential name-based HIV infection reporting

	American Indian/ Alaska Native			Asiana			Black/African American			Hispanic/Latinob			Native Hawaiian/Other Pacific Islander			White			Multiple races			Totalc
	No.	Estimatedd		No.	Estimatedd		No.	Estimatedd		No.	Estimatedd		No.	Estimatedd		No.	Estimatedd		No.	Estimatedd		No.	Estimatedd
		No.	Rate		No.	Rate		No.	Rate		No.	Rate		No.	Rate		No.	Rate		No.	Rate		No.e	Rate
Age at end of year
<13	10	11	2.8	23	25	2.3	1,913	1,998	34.8	493	517	7.3	0	0	0.0	314	328	1.5	34	36	3.6	2,791	2,919	7.9
13–14	1	1	1.6	5	5	3.5	817	839	85.5	235	242	26.8	0	0	0.0	143	147	4.1	13	13	11.9	1,215	1,248	21.6
15–19	23	24	14.5	21	23	6.5	3,613	3,824	151.3	915	964	45.0	0	0	0.0	699	736	7.8	49	53	21.5	5,320	5,624	37.9
20–24	76	83	52.1	85	94	24.9	10,391	11,152	481.7	2,640	2,865	133.6	14	15	133.1	2,860	3,086	33.1	174	187	92.5	16,244	17,486	120.3
25–29	172	185	132.3	224	243	47.6	18,527	19,582	885.8	6,066	6,517	261.5	28	30	214.3	7,720	8,212	89.9	349	372	206.6	33,099	35,154	239.4
30–34	239	251	210.1	464	501	83.1	24,237	25,310	1,317.4	9,340	9,891	412.1	42	45	349.2	12,441	13,078	157.5	424	443	325.2	47,215	49,547	367.1
35–39	404	418	347.8	621	661	110.7	35,929	37,192	1,847.6	14,588	15,274	699.2	36	38	340.8	24,758	25,689	267.9	697	717	570.1	77,128	80,086	546.9
40–44	421	434	343.5	596	632	124.5	48,891	50,318	2,416.9	19,312	20,007	1,031.8	32	33	330.0	39,921	41,098	391.8	896	917	778.1	110,241	113,613	743.9
45–49	396	406	316.1	458	481	108.7	47,297	48,506	2,338.0	17,472	17,967	1,100.0	37	40	452.8	40,079	41,019	355.8	942	959	809.4	106,855	109,553	687.5
50–54	264	271	240.0	300	314	81.9	36,601	37,396	2,058.5	12,055	12,373	969.0	12	12	167.5	27,267	27,822	253.9	612	619	587.6	77,265	78,963	538.5
55–59	117	119	127.9	172	181	56.3	21,715	22,134	1,506.2	6,986	7,152	724.5	13	14	235.5	15,991	16,285	165.5	344	346	400.2	45,454	46,347	362.0
60–64	57	58	85.5	77	80	35.5	9,714	9,908	975.3	3,466	3,550	492.3	11	12	294.3	8,069	8,218	101.0	153	153	230.0	21,594	22,027	215.2
≥65	45	46	32.3	73	76	17.4	8,150	8,306	345.8	2,915	2,984	180.4	5	5	68.7	6,120	6,235	28.3	112	105	73.2	17,465	17,803	66.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact	909	1,055	—	1,318	1,954	—	65,171	87,446	—	34,578	43,908	—	131	165	—	110,637	128,290	—	1,729	2,079	—	214,621	265,330	—
Injection drug use	184	214	—	86	161	—	26,099	37,091	—	13,493	17,781	—	5	7	—	11,074	12,634	—	447	543	—	51,419	68,532	—
Male-to-male sexual contact and injection drug use	209	246	—	58	84	—	8,928	11,902	—	3,604	4,449	—	4	5	—	11,672	12,983	—	262	308	—	24,743	30,037	—
Heterosexual contactf	103	125	—	239	325	—	23,838	35,588	—	6,448	8,246	—	10	14	—	5,274	6,419	—	313	388	—	36,239	51,150	—
Otherg	188	10	—	704	36	—	43,533	909	—	13,704	308	—	32	2	—	18,409	1,450	—	511	23	—	77,524	2,748	—
Subtotal	1,593	1,650	234.4	2,405	2,559	107.4	167,569	172,935	1,621.0	71,827	74,691	703.3	182	194	351.0	157,066	161,776	271.6	3,262	3,341	421.3	404,546	417,797	492.8
Female adult or adolescent
Injection drug use	155	199	—	32	75	—	14,658	22,908	—	4,840	6,813	—	5	7	—	7,656	9,730	—	303	400	—	27,665	40,197	—
Heterosexual contactf	305	418	—	320	588	—	46,123	73,899	—	11,594	16,834	—	24	42	—	13,520	18,653	—	758	1,059	—	72,683	111,629	—
Otherg	144	11	—	318	47	—	34,009	1,141	—	6,536	236	—	19	2	—	6,891	522	—	385	26	—	48,449	1,989	—
Subtotal	604	627	85.3	670	710	28.1	94,790	97,948	805.4	22,970	23,883	242.3	48	51	95.3	28,067	28,905	46.1	1,446	1,485	175.3	148,797	153,814	173.0
Child (<13 yrs at diagnosis)
Perinatal	23	24	—	31	33	—	4,967	5,095	—	1,521	1,561	—	0	0	—	937	959	—	80	81	—	7,563	7,757	—
Otherh	5	5	—	13	13	—	468	484	—	165	170	—	0	0	—	312	313	—	11	10	—	978	1,000	—
Subtotal	28	29	7.6	44	46	4.3	5,435	5,579	97.1	1,686	1,731	24.5	0	0	0.0	1,249	1,272	5.9	91	92	9.3	8,541	8,757	23.6
Totali	2,225	2,306	126.7	3,119	3,315	55.4	267,795	276,464	967.5	96,483	100,304	364.0	230	245	173.6	186,382	191,953	133.3	4,799	4,918	187.2	561,886	580,371	275.4

Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.

See Technical Notes for the list of areas that have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2005.

^a Includes Asian/Pacific Islander legacy cases (see Technical Notes).

^b Hispanics/Latinos can be of any race.

^c Includes persons of unknown race/ethnicity.

^d Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting. Rates are per 100,000 population. Rates not calculated by transmission category because of the lack of denominator data.

^e Because row totals were calculated independently of the values for the subpopulations, the values in each row may not sum to the row total.

^f Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.

^g Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.

^h Includes hemophilia, blood transfusion, and risk factor not reported or not identified.

ⁱ Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.